These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 30366316)

  • 41. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
    Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
    Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, semisynthesis, α-glucosidase inhibitory, cytotoxic, and antibacterial activities of p-terphenyl derivatives.
    Zhang XQ; Mou XF; Mao N; Hao JJ; Liu M; Zheng JY; Wang CY; Gu YC; Shao CL
    Eur J Med Chem; 2018 Feb; 146():232-244. PubMed ID: 29407953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study.
    Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM
    Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
    Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
    Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
    Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B
    Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of α-glucosidase.
    Gupta SJ; Dutta S; Gajbhiye RL; Jaisankar P; Sen AK
    Bioorg Chem; 2017 Jun; 72():11-20. PubMed ID: 28346871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
    Kim JH; Kim HY; Jin CH
    Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and biological evaluation of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide derivatives as α-glucosidase inhibitors.
    Zhang JH; Xie HX; Li Y; Wang KM; Song Z; Zhu KK; Fang L; Zhang J; Jiang CS
    Bioorg Med Chem Lett; 2021 Nov; 52():128413. PubMed ID: 34634473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
    Leong SW; Abas F; Lam KW; Yusoff K
    Bioorg Med Chem Lett; 2018 Feb; 28(3):302-309. PubMed ID: 29292226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
    Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
    Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
    Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.